InsidersTradesSigma
Total declarations
Company
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the full record of transactions filed by Aggarwal Gaurav, Director. Officer active across 1 companies, notably Sierra Oncology, Inc.. Aggregated, 5 disclosures have been recorded. Total volume traded: €38.7m. The latest transaction was filed on 1 July 2022 (Disposition). Regulator: SEC (Form 4). All data is free.
Declarations5 total
€144m2,735,853 shares@ €52.492574.2% of flow
Common Stock
SEC:0001209191-22-040279:0·
€19m800,000 shares@ €24.210110.0% of flow
Common Stock
SEC:0001209191-22-005748:0·
Ideal exit: 28 Oct 2022 (T+270)
€19m800,000 shares@ €24.210177.5% of flow
Common Stock
SEC:0001209191-22-005748·
Ideal exit: 28 Oct 2022 (T+270)
€6m480,277 shares@ €11.676722.5% of flow
Common Stock
SEC:0001209191-22-005503·
€6m480,277 shares@ €11.67672.9% of flow
Common Stock
SEC:0001209191-22-005503:0·
5 of 5 declarations
About Aggarwal Gaurav
Aggarwal Gaurav is a Board Member at Sierra Oncology, Inc. As a board member, he participates in overseeing the company's activities and strategic decision-making. His expertise in biotechnology allows him to provide valuable insights during board discussions. He is committed to promoting Sierra Oncology's mission and ensuring value creation for shareholders.
